Roivant Sciences (ROIV) Non Operating Investment Income: 2021-2025

Historic Non Operating Investment Income for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $55.2 million.

  • Roivant Sciences' Non Operating Investment Income rose 165.64% to $128.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.4 million, marking a year-over-year increase of 1772.85%. This contributed to the annual value of $55.2 million for FY2025, which is 215.04% up from last year.
  • According to the latest figures from FY2025, Roivant Sciences' Non Operating Investment Income is $55.2 million, which was up 215.04% from -$48.0 million recorded in FY2024.
  • Roivant Sciences' Non Operating Investment Income's 5-year high stood at $443.8 million during FY2022, with a 5-year trough of -$48.0 million in FY2024.
  • Moreover, its 3-year median value for Non Operating Investment Income was -$20.8 million (2023), whereas its average is -$4.5 million.
  • As far as peak fluctuations go, Roivant Sciences' Non Operating Investment Income soared by 364.50% in 2022, and later plummeted by 130.47% in 2024.
  • Yearly analysis of 5 years shows Roivant Sciences' Non Operating Investment Income stood at $95.5 million in 2021, then surged by 364.50% to $443.8 million in 2022, then crashed by 104.69% to -$20.8 million in 2023, then tumbled by 130.47% to -$48.0 million in 2024, then surged by 215.04% to $55.2 million in 2025.